LSIPR webinar: BSKB dissects antibody patents

When it comes to patenting antibodies, “written description seems to be the big issue these days”, according to Gerald Murphy, IP partner at law firm Birch Stewart Kolasch Birch (BSKB).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Webinar: antibody patents in Europe and beyond

6 August 2020 Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.

Europe

LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF

22 March 2018 Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.

Americas

Webinar: Plausibility differences determine patent variations in US and EU

28 September 2017 Unlike in Europe, the lack of a plausibility threshold in the US means that those applying for patents there are more likely to be granted a broader claim.

More on this story

Big Pharma

Webinar: antibody patents in Europe and beyond

6 August 2020 Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.

Europe

LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF

22 March 2018 Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.

Americas

Webinar: Plausibility differences determine patent variations in US and EU

28 September 2017 Unlike in Europe, the lack of a plausibility threshold in the US means that those applying for patents there are more likely to be granted a broader claim.

More on this story

Big Pharma

Webinar: antibody patents in Europe and beyond

6 August 2020 Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.

Europe

LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF

22 March 2018 Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure.

Americas

Webinar: Plausibility differences determine patent variations in US and EU

28 September 2017 Unlike in Europe, the lack of a plausibility threshold in the US means that those applying for patents there are more likely to be granted a broader claim.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

LSIPR webinar: BSKB dissects antibody patents

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features